Evidence map›Paper›PMID 31248187›Full record

ArticleBiomedicines2019

Evidence for Contamination of Silica Microparticles in Advanced Platelet-Rich Fibrin Matrices Prepared Using Silica-Coated Plastic Tubes.

Tetsuhiro Tsujino, Akira Takahashi, Sadahiro Yamaguchi, Taisuke Watanabe, Kazushige Isobe, Yutaka Kitamura, Takaaki Tanaka, Koh Nakata, Tomoyuki Kawase

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Nano-titanium coating on glass surface to improve platelet-rich fibrin (PRF) quality.Journal of materials science. Materials in medicine · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Tetsuhiro TsujinoPrivate Practice, Hiroshima 732-0066, Japan. tetsudds@gmail.com.
Akira TakahashiPrivate Practice, Kawasaki 213-0033, Kanagawa, Japan. atakahashihdc@ybb.ne.jp.
Sadahiro YamaguchiPrivate Practice, Ohta 373-0808, Japan. y-sada@mwd.biglobe.ne.jp.
Taisuke WatanabeDivision of Anatomy and Cell Biology of the Hard Tissue, Institute of Medicine and Dentistry, Niigata University, Niigata 951-8514, Japan. watatai@mui.biglobe.ne.jp.
Kazushige IsobeTokyo Plastic Dental Society, Kita-ku, Tokyo 114-0002, Japan. kaz-iso@tc4.so-net.ne.jp.
Yutaka KitamuraDepartment of Oral and Maxillofacial Surgery, Matsumoto Dental University, Shiojiri 399-0781, Japan. shinshu-osic@mbn.nifty.com.
Takaaki TanakaDepartment of Materials Science and Technology, Niigata University, Niigata 950-2181, Japan. tctanaka@eng.niigata-u.ac.jp.
Koh NakataBioscience Medical Research Center, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan. radical@med.niigata-u.ac.jp.
Tomoyuki KawaseDivision of Oral Bioengineering, Institute of Medicine and Dentistry, Niigata University, Niigata 951-8514, Japan. kawase@dent.niigata-u.ac.jp.ORCID 0000-0003-4160-396X
Niigata University · JPMatsumoto Dental University · JPNiigata University Medical and Dental Hospital · JPTokyo Dental College · JP

Funding

Japan Society for the Promotion of Science 18K09595
6 · The paper itself

Abstract

Platelet-rich fibrin (PRF) therapy has been widely applied in regenerative dentistry, and PRF preparation has been optimized to efficiently form fibrin clots using plain glass tubes. Currently, a shortage of commercially available glass tubes has forced PRF users to utilize silica-coated plastic tubes. However, most plastic tubes are approved by regulatory authorities only for diagnostic use and remain to be approved for PRF therapy. To clarify this issue, we quantified silica microparticles incorporated into the PRF matrix. Blood samples were collected into three different brands of silica-containing plastic tubes and were immediately centrifuged following the protocol for advanced-PRF (A-PRF). Advanced-PRF-like matrices were examined using a scanning electron microscope (SEM), and silica microparticles were quantified using a spectrophotometer. Each brand used silica microparticles of specific size and appearance. Regardless of tube brands and individual donors, significant, but not accidental, levels of silica microparticles were found to be incorporated into the A-PRF-like matrix, which will be consequently incorporated into the implantation sites. Presently, from the increasing data for cytotoxicity of amorphous silica, we cannot exclude the possibility that such A-PRF-like matrices negatively influence tissue regeneration through induction of inflammation. Further investigation should be performed to clarify such potential risks.

Indexed as

advanced platelet-rich fibrinamorphous silicablood collection tubecoatinghealth hazard

Identifiers

PMID31248187
PMCPMC6631693
OpenAlexW2949520110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.